Overview

Anti-inflammatories and Adolescent Schizophrenia

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
A double-blind controlled trial assessing the efficacy of anti-inflammatories on symptoms and cognition of adolescents with schizophrenia
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
Treatments:
Anti-Inflammatory Agents
Celecoxib
Minocycline